The letter, written by Sidney Wolfe of Public Citizen's Health Research Group, said that in its first seven months on the market, Crestor was linked to 18 cases of rhabdomyolysis -- a breakdown of ...

AstraZeneca Inc., which makes Crestor, disputes Wolfe's conclusions and says the drug is as safe as any other statin. The company's reviews of the 29 reports of "adverse events" showed they had no ...

A new Crestor investigation, which analyzes muscle and kidney problems reported to the Food and Drug Administration, said the statin should be used only in instances when other statins failed to ...

Crestor, Senay continues, is a much newer drug than Lipitor and Zocor, having only been on the market a little over a year. The first statin hit the market in 1987, and Lipitor, the most popular ...

June 15, 2004 -- Safety problems with the widely used cholesterol drug Crestor have prompted European regulators to tighten prescription guidelines, but experts warn U.S. physicians may not be ...

Contrary to government claims, side effects happen more often with Crestor, a cholesterol-lowering drug that consumer advocates tried to get off the market earlier this year, a new analysis shows ...

There is no doubt that the loss of exclusivity for Crestor and Zetia will impact the bottom lines of AstraZeneca and Merck, respectively. But the availability of the generic forms of these drugs ...

BOSTON-Adverse event reports from the FDA suggest that Crestor is more likely to cause muscle and kidney damage than other major statins (Lipitor, Pravachol or Zocor), researchers here reported in the ...

In the statin wars, there's little question that AstraZeneca's cholesterol-lowering drug Crestor is the most powerful when it comes to lowering LDL, the bad cholesterol, and giving a boost to good ...

Crestor and Lipitor also help prevent heart attacks and strokes. While they’re primarily used in adults, both are approved to treat high cholesterol in children with inherited conditions.

AstraZeneca PLC's chief executive said it is too early to say how an important new study of the cholesterol pill Crestor will affect the drug's sales. As AstraZeneca's stock rose Monday on news of ...